Paid Clinical Trials Plano
Discover 1,711 paid clinical trials in Plano, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
GORE® EXCLUDER®Endovascular AAA Intervention Using the GORE® EXCLUDER® Conformable AAA Endoprosthesis or Iliac Branch Endoprosthesis
Sponsor:
W.L.Gore & Associates
Location:
Code:
NCT06218875
Conditions
AAA - Abdominal Aortic Aneurysm
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
OPSOPS™ With Direct Anterior Approach (DAA)
Sponsor:
Corin
Location:
Code:
NCT04319952
Conditions
Primary Total Hip Arthroplasty
Eligibility Criteria
Sex: All
Age: 21 - 70+
Healthy Volunteers: Not accepted
Interventions
Primary Total Hip Replacement with Metafix™ femoral stem and Trinity™ acetabular cup or TriFit-CF™/TriFit-TS™ femoral stem and Trinity™ acetabular cup implanted by a single surgeon.
EdecesertibStudy of Edecesertib in Participants With Cutaneous Lupus Erythematosus (CLE)
Sponsor:
Gilead Sciences
Location:
Code:
NCT05629208
Conditions
Cutaneous Lupus Erythematosus (CLE)
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Not accepted
Interventions
Edecesertib
Edecesertib Placebo
BEM/RZR vs. SOF/VELC-BEYOND: Efficacy and Safety of BEM/RZR vs. SOF/VEL in Subjects With Chronic HCV
Sponsor:
Atea Pharmaceuticals, Inc.
Location:
Code:
NCT06868264
Conditions
HEPATITIS C VIRUS CHRONIC INFECTION
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Not accepted
Interventions
Bemnifosbuvir-Ruzasvir (BEM/RZR)
Sofosbuvir-Velpatasvir (SOF/VEL)
Macular EdemaA 2-part Study Consisting of a Multiple Ascending Dose Safety Study in Participants With Macular Edema Following Branch Retinal Vein Occlusion and a Dose-finding Safety and Preliminary Efficacy Study in Participants With Either Diabetic Macular Edema or Neovascular Age-related Macular Degeneration
Sponsor:
EyeBiotech Ltd.
Location:
Code:
NCT06664502
Conditions
Diabetic Macular Edema (DME)
Neovascular Age-related Macular Degeneration (NVAMD)
BRVO - Branch Retinal Vein Occlusion
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
EYE201
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Chronic Total OcclusionProspective Global Registry for the Study of Chronic Total Occlusion Intervention
Sponsor:
Minneapolis Heart Institute Foundation
Location:
Code:
NCT02061436
Conditions
Coronary Artery Disease
Eligibility Criteria
Sex: All
Age: 0 - 70+
Healthy Volunteers: Not accepted
BelimumabA Study Describing the Efficacy and Safety of Belimumab Administered in Adult Participants With Early Systemic Lupus Erythematosus (SLE)
Sponsor:
GlaxoSmithKline
Location:
Code:
NCT06411249
Conditions
Systemic Lupus Erythematosus
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Belimumab (GSK1550188)
COronary SInus ReducerEfficacy of the COronary SInus Reducer in Patients With Refractory Angina II
Sponsor:
Shockwave Medical, Inc.
Location:
Code:
NCT05102019
Conditions
Refractory Angina
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Arm 1: treatment with Shockwave Reducer
Arm 2 (control): Implantation procedure with no device implanted
Arm 3 (unblinded, non-randomized): Single arm registry
StentrieverDistal Ischemic Stroke Treatment With Adjustable Low-profile Stentriever
Sponsor:
Rapid Medical
Location:
Code:
NCT05152524
Conditions
Ischemic Stroke
Neovascularization
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Not accepted
Interventions
Tigertriever 13
TenapanorStudy to Assess Safety and Efficacy of Tenapanor for Treatment of IBS-C in Pediatric Patients 12 to Less Than 18 Years
Sponsor:
Ardelyx
Location:
Code:
NCT05643534
Conditions
Irritable Bowel Syndrome With Constipation (IBS-C)
Eligibility Criteria
Sex: All
Age: 12 - 17
Healthy Volunteers: Not accepted
Interventions
Tenapanor 50 MG
Tenapanor 25 mg bid
Placebo